Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Green

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Gastroenterology|July 18, 2014
Common GI Drug Interactions in the ElderlyMarina Kim, Aamir Dam, Jesse Green
Current Treatment Options in Gastroenterology|January 25, 2015
Drug Management in the Elderly IBD PatientMarina Kim, Seymour Katz, Jesse Green
Pharmacoeconomics|September 13, 2005
A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adultsEmily Beth Devine, Zafar Hakim, Jesse Green
Clinics in Geriatric Medicine|November 26, 2013
Gastrointestinal drug interactions affecting the elderlyMandeep Singh, Shawn Chaudhary, Sadra Azizi, et al.
International Journal of Sports Physiology and Performance|March 4, 2021
Not All About the Effort? A Comparison of Playing Intensities During Winning and Losing Game Quarters in BasketballJordan L Fox, Jesse Green, Aaron T Scanlan
AIDS Research and Human Retroviruses|March 21, 2006
Cost-effectiveness of enfuvirtide in HIV therapy for treatment-experienced patients in the United StatesJohn Hornberger, J Michael Kilby, Neil Wintfeld, et al.
HIV Clinical Trials|October 31, 2002
Subcutaneous injection survey: psychometric evaluation of a treatment satisfaction instrument associated with a novel HIV medicationJesse Green, Leah Kleinman, Gabrielle Ciesla, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patientsDavid Bernstein, Leah Kleinman, Chris M Barker, et al.
HIV Clinical Trials|October 30, 2003
Patient acceptance of self-injected enfuvirtide at 8 and 24 weeksCalvin Cohen, James Hellinger, Margaret Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Health-related quality of life with enfuvirtide (ENF; T-20) in combination with an optimized background regimenCalvin J Cohen, Nathan Clumeck, Jean-Michel Molina, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Gastroenterology|July 18, 2014
Common GI Drug Interactions in the ElderlyMarina Kim, Aamir Dam, Jesse Green
Current Treatment Options in Gastroenterology|January 25, 2015
Drug Management in the Elderly IBD PatientMarina Kim, Seymour Katz, Jesse Green
Pharmacoeconomics|September 13, 2005
A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adultsEmily Beth Devine, Zafar Hakim, Jesse Green
Clinics in Geriatric Medicine|November 26, 2013
Gastrointestinal drug interactions affecting the elderlyMandeep Singh, Shawn Chaudhary, Sadra Azizi, et al.
International Journal of Sports Physiology and Performance|March 4, 2021
Not All About the Effort? A Comparison of Playing Intensities During Winning and Losing Game Quarters in BasketballJordan L Fox, Jesse Green, Aaron T Scanlan
AIDS Research and Human Retroviruses|March 21, 2006
Cost-effectiveness of enfuvirtide in HIV therapy for treatment-experienced patients in the United StatesJohn Hornberger, J Michael Kilby, Neil Wintfeld, et al.
HIV Clinical Trials|October 31, 2002
Subcutaneous injection survey: psychometric evaluation of a treatment satisfaction instrument associated with a novel HIV medicationJesse Green, Leah Kleinman, Gabrielle Ciesla, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patientsDavid Bernstein, Leah Kleinman, Chris M Barker, et al.
HIV Clinical Trials|October 30, 2003
Patient acceptance of self-injected enfuvirtide at 8 and 24 weeksCalvin Cohen, James Hellinger, Margaret Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Health-related quality of life with enfuvirtide (ENF; T-20) in combination with an optimized background regimenCalvin J Cohen, Nathan Clumeck, Jean-Michel Molina, et al.
Pageof 3